The Department of Health and Human Services Research Agency halted funding for dozens of ongoing health studies this week, disrupting multiyear research projects that had already faced delays. The Trump administration justified the cuts by citing shifts toward different health priorities, including concerns about childhood overmedication and autism research.
The terminations affected the Agency for Healthcare Research and Quality, which funds comparative effectiveness research and other health studies. At least 67 grants received notice of discontinuation. Many were multiyear awards that researchers had already been waiting to resume after previous indefinite postponements.
The move represents a direct reordering of federal health research priorities under the new administration. Trump officials signaled the agency would redirect resources toward investigating what they frame as overmedication in children and expanding autism-related work. The timing caught many grantees by surprise, as projects had been in limbo waiting for resumption, not termination.
Research organizations expressed concern about the disruption. Abrupt funding cuts destabilize ongoing studies and can force researchers to abandon projects mid-course, potentially wasting preliminary data and delaying findings in areas deemed lower priority. Multiyear grants typically structure budgets and timelines years in advance. Sudden terminations force institutions to absorb costs and reallocate personnel.
The cuts signal the administration's intent to reshape federal research spending toward its preferred health topics. While the government regularly shifts research funding priorities with new administrations, the scope and speed of these cuts raised questions about whether the terminations followed standard review processes or represented a more aggressive purge of existing commitments.
The decision falls under the HHS purview and reflects broader Trump administration moves to consolidate control over federal agencies and redirect spending. Leadership has signaled intent to scrutinize what it views as wasteful or misaligned federal spending. How other research agencies respond remains unclear.